Pharma Mar Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	34.01	26.13	1.14	49.36	92.86	137.26
Depreciation & Amortization	7.07	5.72	4.72	4.89	4.56	4.33
Other Amortization	1.05	1.05	1.03	1.01	1.03	2.88
Loss (Gain) From Sale of Assets	-0.84	-0.84	1.93	-0.01	0.03	0.03
Asset Writedown & Restructuring Costs	-0.28	-0.28	-1.75	1.48	-0.18	0.37
Stock-Based Compensation	-	-	0.3	0.39	0.34	0.27
Provision & Write-off of Bad Debts	-	-	-	-	-	0.02
Other Operating Activities	-6.02	6	14.09	9.42	-11.55	5.84
Change in Accounts Receivable	-7.32	-7.32	1.78	21.61	-26.76	-12.63
Change in Inventory	-12.68	-12.68	-11.54	-17.21	1.4	-3.03
Change in Accounts Payable	11.23	11.23	3.39	1.79	7.19	4.65
Change in Unearned Revenue	-24.93	-24.93	-23.2	-	-	-
Change in Other Net Operating Assets	19.95	1.95	-5.34	-34.41	-43.23	138.95
Operating Cash Flow	21.24	6.03	-13.45	38.32	25.68	278.94
Operating Cash Flow Growth	1187.99%	-	-	49.24%	-90.80%	-
Capital Expenditures	-4.52	-15.02	-14.81	-8.85	-7.8	-3
Sale of Property, Plant & Equipment	0.89	0.89	-	0.01	-	-
Sale (Purchase) of Intangibles	-0.5	-0.5	-1.15	-	-	-
Investment in Securities	17.11	15.66	-27.09	19.72	26.28	-116.01
Other Investing Activities	4.83	-	-	-	-	-
Investing Cash Flow	17.81	1.03	-43.05	10.88	18.47	-119.01
Long-Term Debt Issued	-	15.41	7.2	1.54	5.83	0.83
Total Debt Issued	6.04	15.41	7.2	1.54	5.83	0.83
Long-Term Debt Repaid	-	-9.56	-8.36	-10.2	-15.27	-32.37
Total Debt Repaid	-12.09	-9.56	-8.36	-10.2	-15.27	-32.37
Net Debt Issued (Repaid)	-6.06	5.86	-1.15	-8.66	-9.44	-31.54
Issuance of Common Stock	18.91	18.91	18.61	57.23	33.55	30.37
Repurchase of Common Stock	-23.52	-18.63	-37.9	-50.18	-40.66	-63.71
Common Dividends Paid	-13.95	-11.42	-11.69	-11.76	-10.87	-8.82
Other Financing Activities	-0.07	-0.07	-	-	-	-0.12
Financing Cash Flow	-24.68	-5.35	-32.14	-13.37	-27.42	-73.82
Foreign Exchange Rate Adjustments	0.56	1.51	-1.16	0.64	0.4	-7.54
Net Cash Flow	14.93	3.22	-89.79	36.47	17.14	78.57
Free Cash Flow	16.72	-8.99	-28.25	29.47	17.87	275.94
Free Cash Flow Growth	-	-	-	64.87%	-93.52%	-
Free Cash Flow Margin	9.33%	-5.14%	-17.87%	15.01%	7.78%	102.21%
Free Cash Flow Per Share	0.96	-0.51	-1.58	1.63	0.99	15.06
Cash Interest Paid	2.47	2.47	2.42	2.38	3.37	3.12
Cash Income Tax Paid	-	-23.26	-16.59	-2.72	7.86	9.65
Levered Free Cash Flow	9.81	-20.15	-12.59	33.11	4.75	128.41
Unlevered Free Cash Flow	12.43	-18.61	-11.08	34.6	6.86	130.36
Change in Working Capital	-13.74	-31.75	-34.91	-28.22	-61.41	127.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.